Clinically translatable cytokine delivery platform for cancer immunotherapy

Time: 3:30 pm


  • Describe the development of the LOCOcyteTM, an allogeneic cell-based immunotherapy platform to enable potent localized modulation of the immune system which also precipitates a systemic immune response for cancer immunotherapy
  • Highlight pre clinical data with our LOCOcyteTM platform demonstrating tumor eradication in advanced ovarian cancer, colorectal, and mesothelioma cancer mouse models. Review non human primate safety, pharmacokinetics, and pharmacodynamic data with our LOCOcyteTM platform
  • Describe clinical synopsis of LOCOcyteTM first in human trial for advanced recurrent ovarian cancer patients